|
M.B. Antsiferov (1), O.M. Koteshkova (1), N.A. Demidov (2)
The use of personal systems for continuous monitoring of glycemia in diabetic patients on insulin
|
№4 / 2019
|
|
F.E. Shadrichev (1, 2), T. Yu. Demidova (3), N.N. Grigorieva (2, 4), A.A. Kozhevnikov (3)
Prevention of blindness in diabetes mellitus. From retinal laser coagulation to pharmacology
|
№4 / 2019
|
|
Ya.V. Girsh
Insulin detemir and its place in the diabetes treatment: results of 15-year use
|
№4 / 2019
|
|
I.A. Kurnikova, A.Yu. Yurovsky
Diabetic autonomic neuropathy: problems of diagnosis and therapy
|
№4 / 2019
|
|
P.B. Shorokhova, V.L. Baranov, N.V. Vorokhobina, O.S. Shpilevaya
Genetic predictors of the pharmacological effects of dipeptidyl peptidase-4 inhibitors and sulfonylureas in patients with type 2 diabetes mellitus
|
№4 / 2019
|
|
M.M. Tanashyan (1), M.Yu. Maksimova (1), K.V. Antonova (1), A.A. Raskurazhev (1), N.V. Shakhparonova (1), T.I. Romantsova (2)
Poststroke recovery in patients with type 2 diabetes mellitus
|
№3 / 2019
|
|
A.F.Verbovoy, L.A. Sharonova, S.A. Burakshayev, E.V. Kotelnikova, T.V. Smirnova
OPPORTUNITIES FOR PREVENTION OF CHANGES IN SKIN AND ORAL MUCOSA IN DIABETES MELLITUS AT THE PRESENT STAGE
|
№16 / 2017
|
|
A.Yu. Chikanova (1), L.Yu. Khamnuyeva (1, 2), O.G. Karnoukhova (1), N.S. Sudakova (1), N.P. Tokareva (2)
FEATURES OF URINE MICROFLORA IN DIABETIC PATIENTS
|
№16 / 2017
|
|
M.B. Antsiferov
EFFECT OF SGLT-2 INHIBITORS ON CARDIOVASCULAR OUTCOMES: REVIEW OF RESULTS OF CVD-REAL TRIAL
|
№16 / 2017
|
|
V.Ya. Dzerve
ENERGY METABOLISM CORRECTOR MILDRONATE®: INTERRELATION OF MECHANISMS OF ACTION AND THERAPEUTIC EFFECTS
|
№15 / 2017
|
|
V.N. Shishkova
PROBLEMS OF COMORBID PATIENT AND POLYPRAGMASY IN NEUROLOGY
|
№9 / 2017
|
|
I.A. Zolotovskaya (1), I.L. Davydkin (1), N.Yu. Borovkova (2)
THERAPY WITH NONSTEROID ANTI-INFLAMMATORY DRUGS IN PATIENTS WITH ACUTE NONSPECIFIC LOW BACK PAIN: DYNAMICS OF RENAL FUNCTION: RESULTS OF “PANDA” COGORT STUDY
|
№7 / 2017
|
Русский
